Semaglutide and levothyroxine: what the interaction evidence actually shows

Semaglutide slows gastric emptying, which can delay or reduce absorption of oral levothyroxine, a medicine with a narrow therapeutic window where small absorption changes matter.
No dose adjustment is automatic: thyroid function testing is the tool that shows whether the interaction is clinically significant for you specifically.
Timing levothyroxine correctly (first thing in the morning, well before food and other medicines) is standard practice and becomes even more important when taking a GLP-1 medicine alongside it.
Both your prescribing clinician and anyone managing your thyroid condition should be aware you are taking both medicines; this is a clinical conversation, not one to skip.

Taking semaglutide and levothyroxine together is a question that comes up regularly in clinical practice, and the short answer is that the two medicines can generally be used at the same time — but the interaction is real and worth understanding. Semaglutide slows gastric emptying, which can reduce and delay the absorption of oral medicines taken around the same time, including levothyroxine. Levothyroxine is already one of the most absorption-sensitive medicines in use: it is a prescription-only thyroid hormone with a notoriously narrow therapeutic window, meaning even small shifts in how much reaches your bloodstream can affect thyroid function tests and how you feel. Anyone taking both medicines should have their thyroid function monitored, and their prescribers should know about both. Neither medicine makes the other unsafe in principle, but the combination needs clinical oversight — the NHS semaglutide medicines page advises that slowed gastric emptying may affect the absorption of other oral drugs, and this is exactly the mechanism relevant here.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the semaglutide–levothyroxine interaction works in practice, and what to do about it

Why gastric emptying matters for levothyroxine absorption

Semaglutide works partly by slowing the rate at which the stomach empties its contents into the small intestine. This is useful for weight management (it prolongs the feeling of fullness) but it also means that anything taken orally sits in the stomach longer before reaching the absorptive surface of the gut. For most medicines, this shifts the timing of absorption without dramatically changing the total amount absorbed. Levothyroxine is a different case. It is absorbed primarily in the small intestine, and the conditions around that absorption are unusually important: taking it with food, coffee, calcium, iron or certain other medicines can meaningfully reduce how much gets through. A medicine that slows gastric emptying adds another variable into that already finely balanced picture. The BNF entry for semaglutide notes that delayed gastric emptying may influence the absorption of concomitant oral medicines, and levothyroxine sits squarely in that category. The practical consequence is not that the combination is contraindicated, it is that thyroid function should be monitored after starting or adjusting semaglutide, because the effective levothyroxine dose may shift even without any change to the levothyroxine prescription itself.

What the clinical guidance says, and what it does not say

A question our prescribers hear most weeks is whether someone already stable on levothyroxine needs to stop it, change it, or take it at a completely different time of day before starting semaglutide. The honest answer from current guidance is nuanced. There is no UK regulatory contraindication between the two medicines, and no published randomised trial has specifically tested this combination in a way that produces a definitive dosing protocol. What exists is pharmacokinetic reasoning (sound, well-established reasoning) alongside clinical consensus that thyroid function tests should be checked after semaglutide is initiated or after any dose increase. If you are being assessed for Wegovy or oral semaglutide and you take levothyroxine, the right step is to declare both medicines during your consultation. A prescriber who knows your full medicine list can flag to your GP or endocrinologist that monitoring is warranted. Semaglutide is also subject to ongoing pharmacovigilance as a Black Triangle medicine, which means the evidence base continues to develop; any new interaction signals would be reflected in updated guidance. For a broader picture of medicines that may need attention alongside semaglutide, our page on Wegovy drug interactions covers the fuller list alongside semaglutide's interactions with other drugs.

Practical steps if you take both medicines

Standard levothyroxine counselling already recommends taking it on an empty stomach, first thing in the morning, at least 30 minutes before food and other medicines, ideally 60 minutes. That spacing should be maintained, or extended where possible, when starting semaglutide. The weekly injection of semaglutide does not have a fixed daily administration time in the same way, so there is no conflict about which to take when: the levothyroxine timing is unchanged. What does need attention is the monitoring schedule. Thyroid stimulating hormone (TSH) and free T4 are the standard tests; if you have recently started semaglutide and your thyroid symptoms have changed (fatigue, weight changes (beyond the expected effects of treatment), cold intolerance, heart rate changes) that is a reason to contact your GP rather than wait for a routine review. For context on how semaglutide fits into the broader clinical picture of weight management treatment, those details are covered on the treatment overview. People interested in how semaglutide handles temperature and storage (relevant if your levothyroxine is also refrigerated) can find the specifics at semaglutide storage and temperature guidance. If you have questions specific to your own medicine list, the most direct route is a clinical conversation: interactions with Wegovy gives a structured starting point, and you can also look at whether levothyroxine and semaglutide can be taken together for a more focused answer on that pairing.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions